MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib.
about
MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
MK-2206 sensitizes BRCA-defici ...... oma to cisplatin and olaparib.
@ast
MK-2206 sensitizes BRCA-defici ...... oma to cisplatin and olaparib.
@en
type
label
MK-2206 sensitizes BRCA-defici ...... oma to cisplatin and olaparib.
@ast
MK-2206 sensitizes BRCA-defici ...... oma to cisplatin and olaparib.
@en
prefLabel
MK-2206 sensitizes BRCA-defici ...... oma to cisplatin and olaparib.
@ast
MK-2206 sensitizes BRCA-defici ...... oma to cisplatin and olaparib.
@en
P2093
P2860
P1433
P1476
MK-2206 sensitizes BRCA-defici ...... noma to cisplatin and olaparib
@en
P2093
Alan C Sartorelli
Elena S Ratner
Margaret E Whicker
Z Ping Lin
P2860
P2888
P356
10.1186/S12885-016-2598-1
P407
P50
P577
2016-07-27T00:00:00Z
P6179
1000243831